Abstract: This invention relates the use of cortisol blockers (e.g., glucocorticoid receptor [GR] antagonists) for the treating or preventing viral infections, treating or preventing treatment resistant prostate cancer, treating or preventing neoplasia, and treating or preventing infection related to acute or chronic injury or disease.
Type:
Grant
Filed:
November 21, 2019
Date of Patent:
February 14, 2023
Assignee:
POP TEST ONCOLOGY LLC
Inventors:
Randice Lisa Altschul, Neil David Theise, Andreas J. Kesel, Myron Rapkin, Rebecca O'Brien, Anthony Arment
Abstract: This invention relates the use of cortisol blockers (glucocorticoid receptor [GR] antagonists) for the treating or preventing treatment resistant prostate cancer, treating or preventing neoplasia, and treating or preventing infection related to acute or chronic injury or disease.
Type:
Grant
Filed:
August 3, 2021
Date of Patent:
June 21, 2022
Assignee:
Pop Test Oncology, LLC
Inventors:
Randice Lisa Altschul, Neil David Theise, Myron Rapkin, Rebecca O'Brien
Abstract: This invention relates the use of cortisol blockers (glucocorticoid receptor [GR] antagonists) for the treating or preventing treatment resistant prostate cancer, treating or preventing neoplasia, and treating or preventing infection related to acute or chronic injury or disease.
Type:
Grant
Filed:
January 18, 2019
Date of Patent:
January 21, 2020
Assignee:
POP TEST ONCOLOGY LLC
Inventors:
Randice Lisa Altschul, Neil David Theise, Myron Rapkin, Rebecca O'Brien
Abstract: This invention relates the use of cortisol blockers (e.g., glucocorticoid receptor [GR] antagonists) for the treating or preventing viral infections, treating or preventing treatment resistant prostate cancer, treating or preventing neoplasia, and treating or preventing infection related to acute or chronic injury or disease.
Type:
Grant
Filed:
January 8, 2019
Date of Patent:
December 31, 2019
Assignee:
POP TEST ONCOLOGY LLC
Inventors:
Randice Lisa Altschul, Neil David Theise, Andreas J. Kesel, Myron Rapkin, Rebecca O'Brien, Anthony Arment
Abstract: This invention relates the use of cortisol blockers (e.g., glucocorticoid receptor [GR] antagonists) for the treating or preventing viral infections, treating or preventing treatment resistant prostate cancer, treating or preventing neoplasia, and treating or preventing infection related to acute or chronic injury or disease.
Type:
Grant
Filed:
November 29, 2017
Date of Patent:
March 26, 2019
Assignee:
Pop Test Oncology LLC
Inventors:
Randice Lisa Altschul, Neil David Theise, Andreas J. Kesel, Myron Rapkin, Rebecca O'Brien, Anthony R. Arment
Abstract: This invention relates the use of cortisol blockers (e.g., glucocorticoid receptor [GR] antagonists) for the treating or preventing viral infections, treating or preventing treatment resistant prostate cancer, treating or preventing neoplasia, and treating or preventing infection related to acute or chronic injury or disease.
Type:
Grant
Filed:
December 6, 2016
Date of Patent:
January 2, 2018
Assignee:
Pop Test Oncology LLC
Inventors:
Randice Lisa Altschul, Neil David Theise, Andreas J. Kesel, Myron Rapkin, Rebecca O'Brien, Anthony R. Arment
Abstract: This invention relates the use of cortisol blockers (e.g., glucocorticoid receptor [GR] antagonists) for the treating or preventing viral infections, treating or preventing treatment resistant prostate cancer, treating or preventing neoplasia, and treating or preventing infection related to acute or chronic injury or disease.
Type:
Grant
Filed:
July 28, 2016
Date of Patent:
March 21, 2017
Assignee:
Pop Test Oncology LLC
Inventors:
Randice Lisa Altschul, Neil David Theise, Andreas J. Kesel, Myron Rapkin, Rebecca O'Brien, Anthony R. Arment